Energy & Longevity · Rx required

The Timekeeper Stack

Longevity, taken seriously.

Tier 3 · Early evidence — investigational

The story

Longevity, taken seriously — our most advanced longevity protocol, layering NAD+ with two mitochondria- and aging-focused peptides. Be aware: SS-31 and epithalon are experimental, with limited human evidence.

Why this combination

NAD+ provides the cellular-energy base; SS-31 targets the mitochondria directly; epithalon is included for its proposed effects on cellular-aging pathways. Aimed at the longevity enthusiast who wants the frontier — eyes open about the evidence.

What to expect

NAD+ is the most grounded element. SS-31 is in human trials but not approved, with mixed results so far; epithalon's human evidence is thin and largely from limited sources. An experimental protocol, not a proven longevity regimen.

Risks & considerations

SS-31 and epithalon are experimental, so the headline risk is the unknown — long-term safety isn't established, benefits unproven for wellness use, product quality varies. NAD+ carries the infusion-related effects noted above. Provider-directed precisely because so much is uncharacterized.

Sources

  1. Elamipretide/SS-31 trial program (not approved)
  2. epithalon limited-replication literature
  3. NAD+ precursor trials

What's in the stack

  • NAD+ injection
  • SS-31
  • Epithalon